跳至主要内容
临床试验/CTRI/2022/09/045751
CTRI/2022/09/045751尚未招募未知

A prospective observational cohort study to evaluate the effectiveness and toxicities of standard regimen in elderly patients with De-Novo DLBCL.

Investigator initiated trial0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Inclusion Criteria
  • 1. Newly diagnosed cases of Diffuse Large B cell Lymphoma
  • 2. Age more than or equal to 60 years.
  • 3. Patients who provide written informed consent

排除标准

  • The patients found to meet all inclusion criteria of the study will thereafter be administered the informed
  • consent process

研究者

发起方
Investigator initiated trial

相似试验